ArticleFrontiers in endocrinology2025
High prevalence but low referral rate of adrenal incidentalomas in a Lebanese tertiary hospital.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Graded Electrolyte Disturbances Across the Spectrum of Autonomous Cortisol Secretion in Patients with Adrenal Incidentaloma: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Habitat-radiomics combining multichannel 2.5D deep learning for differentiating adrenal adenomas from metastases using automatic segmentation: a multicenter study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adrenal incidentalomas (AI) are being more frequently reported with the advent of medical imaging. Studies on their prevalence, characteristics and functional status are lacking in the Middle East. Objective: To determine the prevalence of AI as well as their clinical and radiological characteristics and referral rates to endocrinologists for hormonal testing. Methods: We prospectively evaluated unselected adult patients who underwent an abdominal computed tomography (CT) between November 2022 and June 2023 at a Lebanese tertiary teaching hospital. An experienced radiologist carefully reviewed 4,464 CT. Patients with known or suspected malignancy or adrenal disease were excluded. Main outcome measures included prevalence of AI and referral rates to endocrinologists during a one-year follow-up. Results: 3168 CT were retained for analysis, 222 had an AI, with an overall prevalence of 7%. There was no significant difference in prevalence according to gender (8% in women, 6% in men p = .06.). The prevalence increased with age from 0.9% in young adults (18-30 years) to 10.8% in patients older than 70. Mean age of patients with AI was 69 ± 14 years. 46% were males. Median size of AI was 1.7 cm (1.2-2.5). 45% had a density <10 Hounsfield Unit (HU) and 17% were bilateral. Patients with an AI were significantly older (p <.0001), had a higher Body mass index (BMI) (p = .0021), more hypertension (p = .023), dyslipidemia (p = .002), and cardiovascular diseases (CVD) (p = .0056). No difference according to sex was noted. The referral rate of AI to endocrinologists was only 5.4%. Conclusion: The prevalence of AI in Lebanon is comparable to the worldwide prevalence and is linked to age, BMI, hypertension, dyslipidemia and CVD but not to gender. Despite this high prevalence, the rate of referral for appropriate investigations is poor. Raising awareness among clinicians is therefore essential for a better evaluation of these patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.